Reuters logo
BRIEF-Summit Therapeutics reports financial results for Q2 ended July 31 2017
August 31, 2017 / 11:11 AM / in 2 months

BRIEF-Summit Therapeutics reports financial results for Q2 ended July 31 2017

Aug 31 (Reuters) - Summit Therapeutics Plc

* Summit Therapeutics reports financial results for the second quarter and half year ended July 31 2017 and operational progress

* Summit Therapeutics Plc - ‍revenue was £18.9 million for three months ended 31 July 2017 compared to £nil for three months ended 31 July 2016​

* Summit Therapeutics Plc - ‍total comprehensive income for three months ended 31 july 2017 was £10.9 million with a basic earnings per share of 18 pence​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below